1. Home
  2. TRMK vs TARS Comparison

TRMK vs TARS Comparison

Compare TRMK & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trustmark Corporation

TRMK

Trustmark Corporation

HOLD

Current Price

$41.21

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$72.74

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMK
TARS
Founded
1889
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TRMK
TARS
Price
$41.21
$72.74
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$43.50
$80.56
AVG Volume (30 Days)
358.9K
581.1K
Earning Date
04-28-2026
06-01-2026
Dividend Yield
2.34%
N/A
EPS Growth
1.93
48.21
EPS
3.70
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
$9.49
$56.26
Revenue Next Year
$5.17
$26.47
P/E Ratio
$11.57
N/A
Revenue Growth
N/A
146.71
52 Week Low
$29.81
$38.51
52 Week High
$45.43
$85.25

Technical Indicators

Market Signals
Indicator
TRMK
TARS
Relative Strength Index (RSI) 40.61 52.95
Support Level $36.46 $65.62
Resistance Level $45.17 $78.41
Average True Range (ATR) 1.24 3.66
MACD -0.35 0.89
Stochastic Oscillator 20.74 60.90

Price Performance

Historical Comparison
TRMK
TARS

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: